Literature DB >> 26102024

Inhibition of autophagy induces IL-1β release from ARPE-19 cells via ROS mediated NLRP3 inflammasome activation under high glucose stress.

Huanqi Shi1, Zhen Zhang2, Xiaodan Wang3, Ruishu Li4, Wenwen Hou5, Wenjiao Bi6, Xiaomei Zhang7.   

Abstract

Autophagy plays an important role in the development of diabetic retinopathy (DR). Retinal pigment epithelial (RPE) cells are the main cells involved in DR, a process in which hyperglycemia plays a crucial role. This study was conducted to investigate the protective effect of autophagy against high glucose-induced inflammatory response in ARPE-19 cells and its underlying mechanism. In the present study we subjected ARPE-19 cells to high glucose stress and showed that ARPE-19 cells respond to high glucose with an increase in autophagy. 3-methyladenine (3-MA) inhibited occurrence of autophagy and it leaded to the accumulation of damaged-mitochondria-producing-ROS, and the activation of NLRP3 inflammasome, and subsequently, caused IL-1β secretion.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Diabetic retinopathy; NLRP3 inflammasome; Retinal pigment epithelium

Mesh:

Substances:

Year:  2015        PMID: 26102024     DOI: 10.1016/j.bbrc.2015.06.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis.

Authors:  Gaku Tsuji; Akiko Hashimoto-Hachiya; Vu Hai Yen; Masaki Takemura; Ayako Yumine; Kazuhisa Furue; Masutaka Furue; Takeshi Nakahara
Journal:  Cell Death Discov       Date:  2020-03-04

Review 2.  Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy.

Authors:  Sumit Kar; Tyler N Kambis; Paras K Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

3.  Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction.

Authors:  Yang Chen; Lei Wang; Ashley L Pitzer; Xiang Li; Pin-Lan Li; Yang Zhang
Journal:  J Mol Med (Berl)       Date:  2016-10-25       Impact factor: 4.599

4.  High glucose promotes the migration of retinal pigment epithelial cells through increased oxidative stress and PEDF expression.

Authors:  Mitra Farnoodian; Caroline Halbach; Cassidy Slinger; Bikash R Pattnaik; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2016-07-20       Impact factor: 4.249

Review 5.  Shear Stress in Autophagy and Its Possible Mechanisms in the Process of Atherosclerosis.

Authors:  Feng-Xia Guo; Yan-Wei Hu; Lei Zheng; Qian Wang
Journal:  DNA Cell Biol       Date:  2017-03-13       Impact factor: 3.311

6.  Relationship of endothelin-1 and NLRP3 inflammasome activation in HT22 hippocampal cells in diabetes.

Authors:  Rebecca Ward; Adviye Ergul
Journal:  Life Sci       Date:  2016-02-13       Impact factor: 5.037

7.  NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.

Authors:  Rebecca Ward; Weiguo Li; Yasir Abdul; LaDonya Jackson; Guangkuo Dong; Sarah Jamil; Jessica Filosa; Susan C Fagan; Adviye Ergul
Journal:  Pharmacol Res       Date:  2019-02-25       Impact factor: 7.658

Review 8.  Diabetic fibrosis.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-12-28       Impact factor: 5.187

9.  Gambogic acid ameliorates high glucose- and palmitic acid-induced inflammatory response in ARPE-19 cells via activating Nrf2 signaling pathway: ex vivo.

Authors:  Jun Chen; Lihua Li; Yun Zhou; Jiahua Zhang; Lei Chen
Journal:  Cell Stress Chaperones       Date:  2020-11-27       Impact factor: 3.667

Review 10.  Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.

Authors:  Izabela Tuleta; Nikolaos G Frangogiannis
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.